SEC Form D filing
Cresilon, Inc.
Biotech · Series B · Regulation D 506(c) · NY · Filed June 26, 2026
- Offering amount
- $29.0M
- Exemption
- Reg D 506(c)
- Issuer state
- NY
- Filing date
- June 26, 2026
- Signature date
- June 26, 2026
- CIK
- 0001728054
Summary
Auto-generatedCresilon, Inc. is a biotech company raising $29M via 506(c) offering. The $29M amount anchors series-b stage. Form D reports a $29.0M Reg D 506(c) offering from NY, and the issuer name and filed fields support the biotech/series-b classification.
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.